Developer docs
API playgroundTry for free, no card

Search company profiles

InsilicAll

Full company profile

uuid000fmu4

Namestring
InsilicAll
Legal namestring
InsilicAll
Websiteurl
insilicall.com
Company typeenum
Private
Founded yearint
2019
Descriptiontext

InsilicAll is a private AI-driven computational toxicology and regulatory compliance SaaS provider founded in 2019 and headquartered between Durham, North Carolina and São Paulo, Brazil, with additional offices in Rio de Janeiro and Goiânia. The company builds a portfolio of specialized tools on the InsilicAll AI Platform for pharmaceutical, chemical, cosmetics, agrochemical, food, and supplement R&D, including Ionization Pro for pKa, solubility, lipophilicity, and HPLC retention time prediction; Degrad Plus for degradation pathway and API-excipient compatibility prediction; Detoxie, Purge Safe, NitroSafety, and ImpurityGuard for mutagenicity, impurity risk, and nitrosamine assessment under ICH M7 and related guidelines; Phaarm Matchmaker for generative AI-driven polypharmacology profiling; and Reactor Sim for chemical safety and process simulation. Its core technical differentiator is a hybrid architecture combining GFN2-xTB quantum mechanical calculations with Graph Neural Networks, applied to reactivity, ionization, and physicochemical property prediction, with proprietary data assets including 300,000+ experimental retention time data points and a 115+ entry validated excipient database.

The company monetizes through tiered SaaS subscriptions (Academic at $15/month, Professional, Enterprise, and Custom on multi-year contracts) plus service-based revenue streams including expert toxicology and advisory engagements, joint R&D programs in which clients retain IP, and custom AI solution development with co-innovation and licensing models. Go-to-market combines enterprise field sales via product-specific consultation forms with bottom-up self-service through the Academic tier, supported by a Knowledge Hub of regulatory and scientific content. All products are positioned as regulatory-grade with FDA 21 CFR Part 11, ANVISA RDC 658/2022 and RDC 964/2025, ICH M7, and GAMP 5 compliance, with enterprise-tier immutable PDF reports and QR codes integrating into customer QMS, LIMS, and ELN systems. The company is supported institutionally by Brazilian research funding agencies (CNPq, FAPERJ, FAPESP) and was incubated with BiotechTown, but operates with a reported headcount of 1-10 and discloses no outside equity funding amounts or customer logos.

Short descriptiontext

InsilicAll is a Brazil/US-based AI SaaS company providing computational toxicology, drug degradation prediction, and regulatory-grade compliance software for pharmaceutical, chemical, cosmetics, agrochemical, food, and supplement R&D teams, combining quantum mechanical calculations with Graph Neural Networks.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSão Paulo, Brazil
HQ citystring
São Paulo
HQ countrystring
Brazil
HQ regionstring
Latin America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
computational toxicology software, pharmaceutical R&D analytics, AI drug discovery platform, regulatory compliance software, predictive stability modeling
Industry2 codes
PRIMARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAFAM
In Silico / Computational Toxicology & PK/PD Modeling
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)
NAICS code2 codes
  • Computer Systems Design and Related Services5415
  • Instruments and Related Products Manufacturing for Measuring, Displaying, and Controlling Industrial Process Variables334513
SIC code1 code
  • Laboratory Analytical Instruments3826
Product category
Computational Toxicology Software
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
1SaaS Software Licensing
TypeSubscription Recurring
Description

Tiered subscription licensing model for AI-powered toxicology and compliance software tools. Tools can be acquired individually (Ionization Pro, Degrad Plus, Detoxie, Purge Safe, Phaarm Matchmaker) on the InsilicAll AI Platform. Tiers include Academic ($15/month), Professional, Enterprise, and Custom plans.

insilicall.com
2Expert Toxicology & Advisory Services
TypeProfessional Services
Description

Tailored toxicology and advisory services including non-clinical development, safety and risk assessments (environmental, excipient, impurity evaluations), and derivation of safety exposure limits (PDE, OEL). Services support regulatory compliance and drug development strategy optimization.

insilicall.com
3Joint R&D Programs
TypeProfessional Services
Description

Collaborative research programs where InsilicAll's multidisciplinary team of PhD-level biologists, chemists, and toxicologists work as an extension of client teams. Clients fund the project and retain full IP ownership.

insilicall.com
4Custom AI Solutions Development
TypeLicensing Royalties
Description

Development of custom AI platforms tailored to specific R&D challenges in molecular design, formulation development, predictive modeling, regulatory compliance, or process optimization. Clients own the resulting technology completely.

insilicall.com
5AI-Driven Molecule Design & Co-Innovation
TypeLicensing Royalties
Description

Co-creation partnerships for designing novel molecules with targeted properties using generative AI and developing specialized software solutions. Commercial models include co-development agreements, licensing, and revenue-sharing partnerships.

insilicall.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details5 tiers
1Academic - $15/month (or $150/year)
ModelSubscriptionBilling cadenceMonthly
Notes

Unlimited core property predictions (pKa, aqueous solubility, lipophilicity). Designed for students and researchers. Non-commercial use only. Includes self-service documentation.

insilicall.com
2Academic Annual - $150/year
ModelSubscriptionBilling cadenceAnnual
Notes

Annual billing saves the equivalent of 2 months compared to monthly rate. Same features as Academic monthly tier.

insilicall.com
3Professional - Quote-based pricing
ModelSubscriptionBilling cadenceMonthly
Notes

Unlimited pKa predictions, 6 gradient retention time models, full 300k+ retention time database, 2,000 batch calculations/month, organic solvent solubility models (methanol, DMSO, benzene, ethanol), immutable PDF reports (report-level audit trail), FDA/ANVISA compliance, 24-hour support response.

insilicall.com
4Enterprise - Quote-based pricing
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Complete regulatory compliance (login, edits, access audit trails), unlimited batch calculations, custom training sessions, dedicated account management, 4-hour priority support response, API access for programmatic integration, full system-wide audit trails meeting FDA 21 CFR Part 11 and ANVISA RDC 658/2022.

insilicall.com
5Custom - Bespoke pricing
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Flexible tier for organizations requiring expanded capacity, advanced regulatory features, or custom global deployment. Includes high-volume analysis and complex regulatory pipelines.

insilicall.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 9 records shown
1InsilicAll AI Platform
Description

Cloud-based AI platform hosting all InsilicAll SaaS solutions with regulatory compliance features including FDA 21 CFR Part 11 and ANVISA RDC 658/2022.

insilicall.com
+8 more records
Core offering1 text field

InsilicAll develops and licenses a cloud-based SaaS suite of AI-driven computational toxicology and chemistry property prediction tools hosted on the InsilicAll AI Platform. The portfolio includes Ionization Pro (pKa, solubility, retention time, logP/D), Degrad Plus (degradation pathway and API-excipient incompatibility prediction), Detoxie (mutagenicity/carcinogenicity), Purge Safe (ICH M7 purge factor calculations), NitroSafety, ImpurityGuard, Phaarm Matchmaker (generative AI polypharmacology), and Reactor Sim, all built on a hybrid quantum-mechanical/Graph Neural Network architecture and designed for pharmaceutical, chemical, cosmetic, agrochemical, food, and supplement manufacturers operating under FDA, ANVISA, and ICH regulatory frameworks. The company also provides expert toxicology advisory services, joint R&D programs, and custom AI development.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Up to 60% reduction in development time
+1 more record
Product overview1 text field

InsilicAll offers a platform-plus-modules architecture centered on the InsilicAll AI Platform, a cloud-based SaaS hosting specialized AI-driven solutions for pharmaceutical, chemical, cosmetic, and agrochemical R&D. The portfolio includes Ionization Pro for physicochemical property prediction (pKa, solubility, lipophilicity, retention times), Degrad Plus for predictive stability and degradation pathway analysis, Detoxie for mutagenicity and carcinogenicity assessment, Purge Safe for impurity risk assessment and purge factor calculations, NitroSafety for end-to-end nitrosamine risk management, ImpurityGuard for non-mutagenic impurity qualification, Phaarm Matchmaker for generative AI-driven polypharmacology profiling, and Reactor Sim for reactor simulation. All tools support FDA 21 CFR Part 11 and ANVISA RDC 658/2022 compliance, operate independently or synergistically, and can be licensed individually.

Product and service13 records
1InsilicAll AI Platform
CategoryComputational Toxicology Platform
Description

Cloud-based SaaS platform hosting InsilicAll's specialized AI-driven solutions for pharmaceutical, chemical, cosmetic, and agrochemical R&D. Provides regulatory compliance infrastructure including immutable PDF reports, audit trails, FDA 21 CFR Part 11, and ANVISA RDC 658/2022 compliance.

2Ionization Pro
CategoryPhysicochemical Property Prediction
Description

AI-driven software predicting pKa, ionization states, HPLC retention times, logP/logD, and solubility properties for pharmaceutical, cosmetic, agrochemical, and chemical manufacturing applications. Powered by hybrid quantum mechanical (GFN2-xTB) and Graph Neural Network models, and validated against 300,000+ experimental data points.

3Degrad Plus
CategoryDrug Stability Prediction
Description

Predictive stability and formulation design tool enabling rapid elucidation of drug degradation pathways and API-excipient incompatibilities. Combines hybrid quantum-AI reactivity calculations with a 115+ validated excipient knowledge base and five-level formation risk scoring, supporting FDA 21 CFR Part 11 and ANVISA RDC 964/2025 compliance.

4Detoxie
CategoryMutagenicity & Carcinogenicity Assessment
Description

AI-driven mutagenicity and carcinogenicity assessment software boosted with Read-Across (RAx) and expert review, ensuring ICH M7 and 21 CFR Part 11 compliance for pharmaceutical, cosmetic, supplement, and food industries.

5Purge Safe
CategoryICH M7 Impurity Risk Assessment
Description

Standardized AI-driven software for impurity risk assessment and ICH M7 purge factor calculations for API synthesis, serving pharmaceutical, cosmetic, supplement, and food industries.

6NitroSafety
CategoryNitrosamine Risk Management
Description

End-to-end nitrosamine risk management software for pharmaceutical, cosmetic, supplement, and food industries, providing AI-powered read-across, carcinogenicity data analysis, and AI-drafted qualification dossiers for regulatory agencies.

7ImpurityGuard
CategoryNon-Mutagenic Impurity Qualification
Description

In silico qualification tool for non-mutagenic impurities via metabolite identification, API-like comparison, multi-organ toxicophore screening, and quantitative read-across.

8Phaarm Matchmaker
CategoryGenerative AI Drug Discovery
Description

Generative AI software using polypharmacology to map molecular and biological signatures into multi-target profiles, bridging chemistry and biology for drug discovery applications.

9Reactor Sim
CategoryChemical Reactor Simulation
Description

Software solution for AI-driven chemical safety and innovation applications in reactor and process simulation.

10Expert Toxicology & Advisory Services
CategoryExpert Toxicology Services
Description

Tailored expert toxicology and advisory services including non-clinical development, environmental/excipient/impurity safety assessments, and derivation of safety exposure limits (PDE, OEL/OEB). Services include degradation expert assessment, qualification of non-mutagenic impurities, nitrosamine risk assessment, drug-excipient compatibility, residual solvents, elemental impurities, extractables and leachables risk assessment, and read-across data gap filling.

11Joint R&D Programs
CategoryCollaborative R&D Services
Description

Collaborative research programs where InsilicAll's multidisciplinary team of PhD-level biologists, chemists, and toxicologists work as an extension of client teams on drug development, formulation, or toxicology challenges. Clients fund the project and retain full IP ownership of the resulting work.

12Custom AI Solutions Development
CategoryCustom AI Development
Description

Development of custom AI platforms tailored to specific client R&D challenges in molecular design, formulation development, predictive modeling, regulatory compliance, or process optimization. Clients own the resulting technology completely.

13AI-Driven Molecule Design & Co-Innovation
CategoryGenerative AI Co-Innovation
Description

Co-creation partnerships for designing novel molecules with targeted properties using generative AI and developing specialized software solutions. Commercial models include co-development agreements, licensing, and revenue-sharing partnerships.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Operates a physics-based computational chemistry and drug discovery platform with ML-augmented property prediction (including pKa and ADME) and serves pharma R&D globally. Direct competitor for InsilicAll's AI/ML physicochemical property and generative molecule design offerings.

TypeDirect peer
Description

Specializes in in silico ADMET prediction, PBPK modeling, and quantitative systems toxicology used in regulatory submissions. Closely aligned with InsilicAll's computational toxicology and regulatory-submission positioning.

TypeDirect peer
Description

Provides ICH M7-aligned in silico mutagenicity and impurity expert systems (e.g., Derek Nexus, Sarah Nexus), purpose-built for pharmaceutical regulatory workflows. Direct comparable for Detoxie and Purge Safe.

TypeDirect peer
Description

Long-standing vendor of in silico toxicity and metabolism prediction tools (CASE/Ultra), with strong overlap to InsilicAll's mutagenicity, carcinogenicity, and read-across capabilities in regulated chemistry.

TypeDirect peer
Description

Sends regulatory toxicology software (including the former Leadscope QSAR products) into pharma R&D and safety assessment workflows. Comparable buyer base and regulatory-submission value proposition.

TypeBroad incumbent
Description

Offers a broader drug development software suite spanning PBPK, regulatory, and biosimulation tools serving global pharma. Overlaps with InsilicAll on regulatory-grade toxicology and ADME prediction but serves a much wider portfolio.

TypeBroad incumbent
Description

Provides comprehensive scientific informatics including cheminformatics, ADMET, and lab software for pharma and chemicals. InsilicAll sits in a focused slice of BIOVIA's broader R&D informatics scope.

TypeDirect peer
Description

Delivers analytical chemistry and prediction software (pKa, logP, chromatographic retention) widely used in pharma and academic chemistry. Most directly comparable to InsilicAll's Ionization Pro roadmap.

TypeBroad incumbent
Description

Provides R&D scientific informatics and ELN platforms for pharma/biotech. Adjacent infrastructure layer that could bundle or compete with InsilicAll's regulated reporting and LIMS/ELN integration story.

TypeDirect peer
Description

Provides cheminformatics and molecular modeling software used in drug discovery and computational chemistry. Overlaps with InsilicAll's generative AI and property prediction offerings, especially for medicinal chemistry teams.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment8 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature12 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

InsilicAll

Computational Toxicology Softwareinsilicall.com

InsilicAll is a Brazil/US-based AI SaaS company providing computational toxicology, drug degradation prediction, and regulatory-grade compliance software for pharmaceutical, chemical, cosmetics, agrochemical, food, and supplement R&D teams, combining quantum mechanical calculations with Graph Neural Networks.

What InsilicAll does

InsilicAll is a private AI-driven computational toxicology and regulatory compliance SaaS provider founded in 2019 and headquartered between Durham, North Carolina and São Paulo, Brazil, with additional offices in Rio de Janeiro and Goiânia. The company builds a portfolio of specialized tools on the InsilicAll AI Platform for pharmaceutical, chemical, cosmetics, agrochemical, food, and supplement R&D, including Ionization Pro for pKa, solubility, lipophilicity, and HPLC retention time prediction; Degrad Plus for degradation pathway and API-excipient compatibility prediction; Detoxie, Purge Safe, NitroSafety, and ImpurityGuard for mutagenicity, impurity risk, and nitrosamine assessment under ICH M7 and related guidelines; Phaarm Matchmaker for generative AI-driven polypharmacology profiling; and Reactor Sim for chemical safety and process simulation. Its core technical differentiator is a hybrid architecture combining GFN2-xTB quantum mechanical calculations with Graph Neural Networks, applied to reactivity, ionization, and physicochemical property prediction, with proprietary data assets including 300,000+ experimental retention time data points and a 115+ entry validated excipient database.

The company monetizes through tiered SaaS subscriptions (Academic at $15/month, Professional, Enterprise, and Custom on multi-year contracts) plus service-based revenue streams including expert toxicology and advisory engagements, joint R&D programs in which clients retain IP, and custom AI solution development with co-innovation and licensing models. Go-to-market combines enterprise field sales via product-specific consultation forms with bottom-up self-service through the Academic tier, supported by a Knowledge Hub of regulatory and scientific content. All products are positioned as regulatory-grade with FDA 21 CFR Part 11, ANVISA RDC 658/2022 and RDC 964/2025, ICH M7, and GAMP 5 compliance, with enterprise-tier immutable PDF reports and QR codes integrating into customer QMS, LIMS, and ELN systems. The company is supported institutionally by Brazilian research funding agencies (CNPq, FAPERJ, FAPESP) and was incubated with BiotechTown, but operates with a reported headcount of 1-10 and discloses no outside equity funding amounts or customer logos.

InsilicAll firmographics

Firmographics
Name
InsilicAll
Legal name
InsilicAll
Website
https://insilicall.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
1–10 employees
Short description
InsilicAll is a Brazil/US-based AI SaaS company providing computational toxicology, drug degradation prediction, and regulatory-grade compliance software for pharmaceutical, chemical, cosmetics, agrochemical, food, and supplement R&D teams, combining quantum mechanical calculations with Graph Neural Networks.
Ownership category
akta.pro rank

InsilicAll industry classification

Industry
Product category
Computational Toxicology Software
NAICS
Computer Systems Design and Related Services (5415), Instruments and Related Products Manufacturing for Measuring, Displaying, and Controlling Industrial Process Variables (334513)
SIC
Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAFAM
In Silico / Computational Toxicology & PK/PD Modeling
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)

Keywords

  • Computational toxicology software
  • Pharmaceutical R&D analytics
  • AI drug discovery platform
  • Regulatory compliance software
  • Predictive stability modeling

Where InsilicAll is headquartered

Location

Headquarters

HQ city
São Paulo
HQ country
Brazil
HQ region
Latin America

Offices4 records

Markets served

InsilicAll business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. SaaS Software Licensing: Tiered subscription licensing model for AI-powered toxicology and compliance software tools. Tools can be acquired individually (Ionization Pro, Degrad Plus, Detoxie, Purge Safe, Phaarm Matchmaker) on the InsilicAll AI Platform. Tiers include Academic ($15/month), Professional, Enterprise, and Custom plans.
  2. Expert Toxicology & Advisory Services: Tailored toxicology and advisory services including non-clinical development, safety and risk assessments (environmental, excipient, impurity evaluations), and derivation of safety exposure limits (PDE, OEL). Services support regulatory compliance and drug development strategy optimization.
  3. Joint R&D Programs: Collaborative research programs where InsilicAll's multidisciplinary team of PhD-level biologists, chemists, and toxicologists work as an extension of client teams. Clients fund the project and retain full IP ownership.
  4. Custom AI Solutions Development: Development of custom AI platforms tailored to specific R&D challenges in molecular design, formulation development, predictive modeling, regulatory compliance, or process optimization. Clients own the resulting technology completely.
  5. AI-Driven Molecule Design & Co-Innovation: Co-creation partnerships for designing novel molecules with targeted properties using generative AI and developing specialized software solutions. Commercial models include co-development agreements, licensing, and revenue-sharing partnerships.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyAcademic - $15/month (or $150/year)
SubscriptionAnnualAcademic Annual - $150/year
SubscriptionMonthlyProfessional - Quote-based pricing
SubscriptionMulti-year contractEnterprise - Quote-based pricing
SubscriptionMulti-year contractCustom - Bespoke pricing

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

InsilicAll product offering

Product offering

Core offering

InsilicAll develops and licenses a cloud-based SaaS suite of AI-driven computational toxicology and chemistry property prediction tools hosted on the InsilicAll AI Platform. The portfolio includes Ionization Pro (pKa, solubility, retention time, logP/D), Degrad Plus (degradation pathway and API-excipient incompatibility prediction), Detoxie (mutagenicity/carcinogenicity), Purge Safe (ICH M7 purge factor calculations), NitroSafety, ImpurityGuard, Phaarm Matchmaker (generative AI polypharmacology), and Reactor Sim, all built on a hybrid quantum-mechanical/Graph Neural Network architecture and designed for pharmaceutical, chemical, cosmetic, agrochemical, food, and supplement manufacturers operating under FDA, ANVISA, and ICH regulatory frameworks. The company also provides expert toxicology advisory services, joint R&D programs, and custom AI development.

Product overview

InsilicAll offers a platform-plus-modules architecture centered on the InsilicAll AI Platform, a cloud-based SaaS hosting specialized AI-driven solutions for pharmaceutical, chemical, cosmetic, and agrochemical R&D. The portfolio includes Ionization Pro for physicochemical property prediction (pKa, solubility, lipophilicity, retention times), Degrad Plus for predictive stability and degradation pathway analysis, Detoxie for mutagenicity and carcinogenicity assessment, Purge Safe for impurity risk assessment and purge factor calculations, NitroSafety for end-to-end nitrosamine risk management, ImpurityGuard for non-mutagenic impurity qualification, Phaarm Matchmaker for generative AI-driven polypharmacology profiling, and Reactor Sim for reactor simulation. All tools support FDA 21 CFR Part 11 and ANVISA RDC 658/2022 compliance, operate independently or synergistically, and can be licensed individually.

Differentiator

Problem solved

Functional benefit

Brands

  • InsilicAll AI Platform: Cloud-based AI platform hosting all InsilicAll SaaS solutions with regulatory compliance features including FDA 21 CFR Part 11 and ANVISA RDC 658/2022.
  • Ionization Pro
  • Degrad Plus
  • Detoxie
  • Purge Safe
  • Phaarm Matchmaker
  • Reactor Sim
  • Impurity Guard
  • NitroSafety

Products and services

  • InsilicAll AI Platform Cloud-based SaaS platform hosting InsilicAll's specialized AI-driven solutions for pharmaceutical, chemical, cosmetic, and agrochemical R&D. Provides regulatory compliance infrastructure including immutable PDF reports, audit trails, FDA 21 CFR Part 11, and ANVISA RDC 658/2022 compliance.
  • Ionization Pro AI-driven software predicting pKa, ionization states, HPLC retention times, logP/logD, and solubility properties for pharmaceutical, cosmetic, agrochemical, and chemical manufacturing applications. Powered by hybrid quantum mechanical (GFN2-xTB) and Graph Neural Network models, and validated against 300,000+ experimental data points.
  • Degrad Plus Predictive stability and formulation design tool enabling rapid elucidation of drug degradation pathways and API-excipient incompatibilities. Combines hybrid quantum-AI reactivity calculations with a 115+ validated excipient knowledge base and five-level formation risk scoring, supporting FDA 21 CFR Part 11 and ANVISA RDC 964/2025 compliance.
  • Detoxie AI-driven mutagenicity and carcinogenicity assessment software boosted with Read-Across (RAx) and expert review, ensuring ICH M7 and 21 CFR Part 11 compliance for pharmaceutical, cosmetic, supplement, and food industries.
  • Purge Safe Standardized AI-driven software for impurity risk assessment and ICH M7 purge factor calculations for API synthesis, serving pharmaceutical, cosmetic, supplement, and food industries.
  • NitroSafety End-to-end nitrosamine risk management software for pharmaceutical, cosmetic, supplement, and food industries, providing AI-powered read-across, carcinogenicity data analysis, and AI-drafted qualification dossiers for regulatory agencies.
  • ImpurityGuard In silico qualification tool for non-mutagenic impurities via metabolite identification, API-like comparison, multi-organ toxicophore screening, and quantitative read-across.
  • Phaarm Matchmaker Generative AI software using polypharmacology to map molecular and biological signatures into multi-target profiles, bridging chemistry and biology for drug discovery applications.
  • Reactor Sim Software solution for AI-driven chemical safety and innovation applications in reactor and process simulation.
  • Expert Toxicology & Advisory Services Tailored expert toxicology and advisory services including non-clinical development, environmental/excipient/impurity safety assessments, and derivation of safety exposure limits (PDE, OEL/OEB). Services include degradation expert assessment, qualification of non-mutagenic impurities, nitrosamine risk assessment, drug-excipient compatibility, residual solvents, elemental impurities, extractables and leachables risk assessment, and read-across data gap filling.
  • Joint R&D Programs Collaborative research programs where InsilicAll's multidisciplinary team of PhD-level biologists, chemists, and toxicologists work as an extension of client teams on drug development, formulation, or toxicology challenges. Clients fund the project and retain full IP ownership of the resulting work.
  • Custom AI Solutions Development Development of custom AI platforms tailored to specific client R&D challenges in molecular design, formulation development, predictive modeling, regulatory compliance, or process optimization. Clients own the resulting technology completely.
  • AI-Driven Molecule Design & Co-Innovation Co-creation partnerships for designing novel molecules with targeted properties using generative AI and developing specialized software solutions. Commercial models include co-development agreements, licensing, and revenue-sharing partnerships.

Quantifiable outcome

  • Up to 60% reduction in development time
  • +1 more outcomes

Companies that use InsilicAll

Customer profile

Segments8 records

Ideal customer profiles5 records

InsilicAll technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability5 records

Feature12 records

InsilicAll partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

InsilicAll competitors and assessment

Company assessment

Direct peers

  • Schrödinger: Operates a physics-based computational chemistry and drug discovery platform with ML-augmented property prediction (including pKa and ADME) and serves pharma R&D globally. Direct competitor for InsilicAll's AI/ML physicochemical property and generative molecule design offerings.
  • Simulations Plus: Specializes in in silico ADMET prediction, PBPK modeling, and quantitative systems toxicology used in regulatory submissions. Closely aligned with InsilicAll's computational toxicology and regulatory-submission positioning.
  • Lhasa Limited: Provides ICH M7-aligned in silico mutagenicity and impurity expert systems (e.g., Derek Nexus, Sarah Nexus), purpose-built for pharmaceutical regulatory workflows. Direct comparable for Detoxie and Purge Safe.
  • MultiCASE / MN-AM: Long-standing vendor of in silico toxicity and metabolism prediction tools (CASE/Ultra), with strong overlap to InsilicAll's mutagenicity, carcinogenicity, and read-across capabilities in regulated chemistry.
  • Instem: Sends regulatory toxicology software (including the former Leadscope QSAR products) into pharma R&D and safety assessment workflows. Comparable buyer base and regulatory-submission value proposition.
  • ACD/Labs: Delivers analytical chemistry and prediction software (pKa, logP, chromatographic retention) widely used in pharma and academic chemistry. Most directly comparable to InsilicAll's Ionization Pro roadmap.
  • OpenEye Cadence: Provides cheminformatics and molecular modeling software used in drug discovery and computational chemistry. Overlaps with InsilicAll's generative AI and property prediction offerings, especially for medicinal chemistry teams.

Broad incumbents

  • Certara: Offers a broader drug development software suite spanning PBPK, regulatory, and biosimulation tools serving global pharma. Overlaps with InsilicAll on regulatory-grade toxicology and ADME prediction but serves a much wider portfolio.
  • Dassault Systèmes BIOVIA: Provides comprehensive scientific informatics including cheminformatics, ADMET, and lab software for pharma and chemicals. InsilicAll sits in a focused slice of BIOVIA's broader R&D informatics scope.
  • DOTMATICS: Provides R&D scientific informatics and ELN platforms for pharma/biotech. Adjacent infrastructure layer that could bundle or compete with InsilicAll's regulated reporting and LIMS/ELN integration story.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

InsilicAll social profiles

Digital presence

InsilicAll compliance and trust

Trust signal

Compliance3 records

InsilicAll financial estimates

Financial estimate

Revenue estimate

Valuation estimate

InsilicAll leadership team

Management profile

Number of profiles

InsilicAll funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

InsilicAll M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about InsilicAll

What does InsilicAll do?

InsilicAll develops and licenses a cloud-based SaaS suite of AI-driven computational toxicology and chemistry property prediction tools hosted on the InsilicAll AI Platform. The portfolio includes Ionization Pro (pKa, solubility, retention time, logP/D), Degrad Plus (degradation pathway and API-excipient incompatibility prediction), Detoxie (mutagenicity/carcinogenicity), Purge Safe (ICH M7 purge factor calculations), NitroSafety, ImpurityGuard, Phaarm Matchmaker (generative AI polypharmacology), and Reactor Sim, all built on a hybrid quantum-mechanical/Graph Neural Network architecture and designed for pharmaceutical, chemical, cosmetic, agrochemical, food, and supplement manufacturers operating under FDA, ANVISA, and ICH regulatory frameworks. The company also provides expert toxicology advisory services, joint R&D programs, and custom AI development.

Is InsilicAll a public or private company?

InsilicAll is a private company. It is classified as unknown and is currently operating.

When was InsilicAll founded?

InsilicAll was founded in 2019. It employs 1 to 10 people.

Where is InsilicAll based?

InsilicAll is headquartered in São Paulo, Brazil, in the Latin America region.

How does InsilicAll make money?

Five revenue lines are on record. SaaS Software Licensing is the primary driver. The others are expert Toxicology & Advisory Services, joint R&D Programs, custom AI Solutions Development and AI-Driven Molecule Design & Co-Innovation.

Who are InsilicAll's main competitors?

Direct peers on record are Schrödinger, Simulations Plus, Lhasa Limited, MultiCASE / MN-AM, Instem, ACD/Labs and OpenEye Cadence. Broad incumbents are Certara, Dassault Systèmes BIOVIA and DOTMATICS.

Does InsilicAll have an API?

Yes. Enterprise licenses include optional API access for programmatic integration with existing workflows. The platform generates immutable PDF reports with embedded QR codes that integrate directly with quality management systems (QMS), laboratory information management systems (LIMS), and electronic lab notebooks (ELNs). API access is available only for Enterprise tier licenses; Professional and Academic tiers do not include API access. Developer documentation is at insilicall.com/contact-form-ip-enterprise-sales.

What industry is InsilicAll in?

InsilicAll's product category is Computational Toxicology Software. Its primary akta.pro industry code is HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization, with a secondary code of HLAGAFAM, In Silico / Computational Toxicology & PK/PD Modeling. Its NAICS code is 5415 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales